Employees: 428
Size SR Medical Technology (0108.HK) is a Hong Kong Real Estate company (Real Estate Development) with a market value of $1.16B, the 547th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.82 on 18 Nov 2026.
Performance Over six months the shares gained 18.5%, against -11.9% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue grew 24.5% over the last twelve months (peer median -2.7%); the operating margin is 3.6% (peer median 16.2%).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$404M | HK$349M | HK$340M | HK$377M | HK$392M |
| Revenue growth | — | +3% | -10% | -4% | — |
| Gross profit | n/a | n/a | HK$337M | HK$373M | HK$382M |
| EBITDA | HK$21.4M | HK$67.4M | HK$85.2M | HK$144M | HK$141M |
| Net income | -HK$182M | -HK$110M | -HK$919M | -HK$129M | -HK$320M |
| Free cash flow | HK$147M | HK$14.2M | -HK$42.3M | HK$15.4M | -HK$180M |
| Capital expenditure | HK$1.26M | HK$2.73M | HK$1.15M | HK$965,000 | HK$922,000 |
| Total debt | n/a | HK$4.05B | HK$3.83B | HK$3.87B | HK$3.56B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 0108.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -0.5% | -5.4% | 7th highest of 21 |
| 6-month return | +18.5% | -11.9% | 3rd highest of 21 |
| Distance from 52-week high | -34.1% | -33.0% | 11th highest of 21 |
| Revenue growth (TTM) | +24.5% | -2.7% | 4th highest of 21 |
| Operating margin | 3.6% | 16.2% | 5th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| SR Medical Technology 0108.HK | Hong Kong | $1.16B | +18% | +25% | 4% | n/a | n/a | n/a |
| Wedge Industrial 000534.SZ | China | $1.16B | -58% | +4% | 10% | n/a | n/a | n/a |
| Token 1766.T | Japan | $1.15B | +4% | +5% | 6% | n/a | n/a | n/a |
| Tosei 8923.T | Japan | $1.18B | +20% | +14% | 23% | n/a | n/a | n/a |
| Opendoor Technologies OPEN | United States | $1.18B | -71% | -29% | -19% | n/a | n/a | n/a |
| Mainstreet Equity MEQ.TO | Canada | $1.14B | +6% | +5% | 60% | n/a | n/a | n/a |
| Forestar FOR | United States | $1.14B | -14% | -2% | 13% | n/a | n/a | n/a |
| Art 0565.HK | Hong Kong | $1.19B | +15% | +51% | 60% | n/a | n/a | n/a |
| Frey FREY.PA | France | $1.19B | -2% | +45% | 49% | n/a | n/a | n/a |
| China Overseas Grand Oceans 0081.HK | Hong Kong | $1.20B | -10% | -3% | 5% | n/a | n/a | n/a |
| Ichigo 2337.T | Japan | $1.12B | -8% | -17% | 29% | n/a | n/a | n/a |
| Icade ICAD.PA | France | $1.22B | -28% | -9% | 17% | n/a | n/a | n/a |
| Red Star Macalline 1528.HK | Hong Kong | $1.11B | -35% | -3% | -24% | n/a | n/a | n/a |
| Tibet Urban Development & Investment 600773.SS | China | $1.09B | -63% | -78% | -124% | n/a | n/a | n/a |
| Seazen 1030.HK | Hong Kong | $1.24B | -34% | -35% | 16% | n/a | n/a | n/a |
| Sri Lotus Developers and Realty LOTUSDEV.NS | India | $1.24B | +71% | +40% | 38% | n/a | n/a | n/a |
| IRSA Inversiones y Representaciones SA Sponsored ADR IRS | United States | $1.08B | -17% | +9% | 42% | n/a | n/a | n/a |
| Shenzhen Zhenye (Group) 000006.SZ | China | $1.08B | -44% | -56% | 0% | n/a | n/a | n/a |
| Zhuhai Zhumian 600185.SS | China | $1.08B | -28% | -49% | 17% | n/a | n/a | n/a |
| AEDAS Homes AEDAS.MC | Spain | $1.07B | +2% | -25% | 10% | n/a | n/a | n/a |
| First Sponsor ADN.SI | Singapore | $1.07B | -7% | -8% | 22% | n/a | n/a | n/a |